Effects of Antioxidant SS-31 Peptide on Hippocampal Apoptosis and In-flammatory Response in the Mice with Sepsis

YANG Jiao-jiao,QIU Li-li,HAN Jin-feng,WU Jing,YANG Jiang-jun
DOI: https://doi.org/10.13664/j.cnki.pcr.2014.05.034
2014-01-01
Abstract:Objective: To observe the effects of antioxidant SS-31 on hippocampal apoptosis and in-flammatory response in the mice with sepsis. Methods: Sixty five C57BL/6 male mice were randomly di-vided into 3 groups: sham operation group (Sham group, n=15), CLP group (CLP group, n=25), and CLP+SS-31 peptide group (SS-31 peptide group, n=25). The model of sepsis was established by cecal ligation and puncture (CLP) in the mice of CLP and SS-31 peptide groups. Mice received an administration of SS-31 peptide (5 mg·kg-1) immediately and once daily for 6 consecutive days after the operation in the SS-31 peptide group or equal volume of saline in the Sham and CLP groups. At the 7th day, mortality was recorded. After that, the mice were sacrificed to obtain the hippocampus. Reactive oxygen species (ROS) assay kit was used to detect the level of mitochondrial ROS; Western blotting was used to detect the con-tents of total and cytosolic cytochrome C (Cyt C), caspase 3 and Nlrp 3; and enzyme linked immunosorbent assay (ELISA) was used to quantify the levels of interleukin-1β (IL-1β) and neuron specific enolase (NSE). Results: Compared with the CLP group, the mortality of mice was reduced from 52% to 24%, and the hippocampal levels of mitochondrial ROS, cytosolic Cyt C, caspase 3, Nlrp 3, IL-1β and NSE were all de-creased in the SS-31 peptide group (P<0.05). Conclusion: SS-31 peptide can reduce the hippocampal mi-tochondrial ROS generation, inhibit the hippocampal neuronal apoptosis and inflammatory response, amelio-rate the injury and improve the mortality of mice with sepsis.
What problem does this paper attempt to address?